Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylphosphine | HCID 27365 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | HCID 86650163 | HCID 86650163 | — |
| Product | HCID 66926083 | HCID 66926083 | 38.9% |
Reaction Steps
(+/−)-Ethanesulfonyl-trans-4-methyl-piperidine-3-carboxylic acid N′-[5-(2-trimethylsilanyl-ethoxymethyl)-5H-pyrrolo[2,3-b]pyrazin-2-yl]-hydrazide (107 mg, 0.22 mmol) was cyclized to triazolo-tricyclic product using similar conditions to those described in example 17 above [however, after over-night stirring an extra 4 equivalents of N,N-diisopropylethylamine and an extra 3 equivalents of triethylphosphine were added and the mixture was stirred an extra 6 hours before work up]. The crude product was purified by preparative TLC, eluting with 90% ethyl acetate in hexanes. The impure product was collected and purified again by preparative TLC eluting first with 3.75% methanol in methylene chloride and then a second time with 5% methanol in methylene chloride. The product band was collected to afford 41 mg of (+/−)-1-(1-ethanesulfonyl-trans-4-methyl-piperidin-3-yl)-6-(2-trimethylsilanyl-ethoxymethyl)-6H-2,3,5,6,8b-pentaaza-as-indacene as a light yellow-white powder. MS (M+H)+=479.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08361962B2 |
|---|
| Source dataset | uspto-grants-2013_01 |
|---|
| ORD ID | ord-430b5479d2e04a9ea629cdfff384f0b7 |
|---|
| Source note | uspto-grants-2013_01 |
|---|